Mary has served as a member of Enterome’s Board since 2017. She is a biopharmaceutical leader with more than 25 years’ experience in the life sciences industry, serving in senior finance, operations, and business development roles. Mary also serves on the Boards of Homology Medicines, Entrada Therapeutics, Alaunos Therapeutics, Vigil Neurosciense and most recently served as a Special Advisor and Chief of Staff to the CEO at the Bill and Melinda Gates Medical Research Institute.

She began her career as a Certified Public Accountant received her B.A in business and accounting from the University of Massachusetts.